CD40 and arthritic joint disease: Agonistic monoclonal antibodies to CD40 reduced collagen-induced arthritis, possibly through upregulation of IL-10 and to lesser extent IL-4 [33], indicating an anti-inflammatory role in addition to the pro-inflammatory role of CD40.